comparemela.com

Latest Breaking News On - Translational sarcoma research - Page 1 : comparemela.com

Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting

– Company Presents Poster on Overall Survival and Long-Term Safety Results from INTRIGUE Study; Second Poster Presents Analysis from INTRIGUE Patients without Detectable ctDNA at Baseline. | May 25, 2023

Hong kongUnited statesUnited kingdomNew zealandWest germanSebastian bauerJonathan trentSuzanne georgeRobinl jonesMatthewl shermanTranslational sarcoma researchInstitute of cancer researchDeciphera pharmaceuticalsGerman cancer consortiumDana farber cancer instituteDeciphera pharmaceuticals inc

Another Drug Targeting NOTCH Shows Promise for Desmoid Tumors

The long wait for targeted systemic therapies to manage desmoid tumors could be over after a second drug directed against the Notch pathway has shown promise.

France generalUnited kingdomCity ofSebastian bauerRobinl jonesAlliance clinical trials in oncologyInstitute of cancer researchEuropean society for medical oncologyTranslational sarcoma research groupUniversity duisburgCancer researchEuropean societyMedical oncologyTranslational sarcoma researchUniversity duisburg essenClinical trials

vimarsana © 2020. All Rights Reserved.